Hexamethylmelamine use in the treatment of metastatic breast cancer.
Henderson
I C
IC
Breast Evaluation Centre, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Shapiro
C L
CL
D006585:Altretamine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis
D000970:Antineoplastic Agents; D006585:Altretamine